The first reported case of acute ischemic stroke treated with tissue plasminogen activator at Mansoura University, Egypt
Recombinant Tissue Plasminogen Activator (rTPA) is the standard of care for treatment of acute ischemic stroke. Nevertheless, its widespread use in Egypt is hindered by many factors. We report on the first case of acute ischemic stroke to be treated with rTPA at our University hospitals. She receive...
Main Authors: | Ahmed Farouk Donia, Nourelsabah Mohamed Elbialy, Nada Abdelhameed Elsaid, Ayman Fathi Refaie |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2017-12-01
|
Series: | Egyptian Journal of Critical Care Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S209073031730035X |
Similar Items
-
Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
by: Sanjith Aaron, et al.
Published: (2020-12-01) -
Intravenous thrombolysis with rt-plasminogen activator in patients with acute ischemic stroke: clinical experience from two Egyptian centers
by: Nabil Mohamed, et al.
Published: (2020-01-01) -
Effect of Tissue Plasminogen Activator on Treatment Outcome and Neuronal Degeneration in Acute Ischemic Stroke
by: Muhammad Masoud, et al.
Published: (2021-01-01) -
Does intravenous administration of recombinant tissue plasminogen activator for ischemic stroke can cause inferior myocardial infarction?
by: Mostafa Almasi, et al.
Published: (2016-06-01) -
Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: An unknown danger
by: Adatia Sweta, et al.
Published: (2010-01-01)